Cysteine is one of the amino acid residues most frequently exploited in targeted covalent drug discovery. Its side-chain thiol has substantial nucleophilic potential and can form stable covalent bonds with electrophilic groups such as acrylamides. Targeted covalent inhibitors typically first ...
Targeted covalent inhibitors (TCIs) first form a noncovalent complex with the target protein and then form a covalent bond with a specific amino acid residue near the binding pocket. Their development focuses on increasing target occupancy and duration of action while controlling warhead ...
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.